Document:

Exhibit 10.4

 

VIMEO, INC.

2021 STOCK AND ANNUAL INCENTIVE PLAN

 

Section
1.           
PURPOSE; DEFINITIONS

 

The purposes of this Plan are to give the Company
a competitive advantage in attracting, retaining and motivating officers, employees, directors and/or consultants and to provide the Company
and its Subsidiaries and Affiliates with a stock and incentive plan providing incentives directly linked to stockholder value. Certain
terms used herein have definitions given to them in the first place in which they are used. In addition, for purposes of this Plan, the
following terms are defined as set forth below:

 

(a)           
“Adjusted Award” means (i) any equity-based award granted by IAC that is converted into an equity-based award
relating to the Company upon the occurrence of a separation of the Company from IAC, or (ii) any equity-based award granted by Vimeo.com,
Inc. (f/k/a Vimeo, Inc.) that is converted into an equity-based award relating to the Company in connection with a separation of the Company
from IAC.

 

(b)          
“Affiliate” means a corporation or other entity controlled by, controlling or under common control with, the
Company.

 

(c)           
“Affiliated Persons” means, with respect to any specified Person, (i) such specified Person’s parents,
spouse, siblings, descendants, step children, step grandchildren, nieces and nephews and their respective spouses, (ii) the estate, legatees
and devisees of such specified Person and each of the Persons referred to in clause (i), and (iii) any company, partnership, trust or
other entity or investment vehicle controlled by any of the Persons referred to in clause (i) or (ii) or the holdings of which are for
the primary benefit of any of such Persons.

 

(d)          
“Applicable Exchange” means the NASDAQ or such other securities exchange as may at the applicable time be the
principal market for the Common Stock.

 

(e)           
“Award” means an Option, Stock Appreciation Right, Restricted Stock, Restricted Stock Unit, other stock-based
award or Cash-Based Award granted or assumed pursuant to the terms of this Plan.

 

(f)            
“Award Agreement” means a written or electronic document or agreement setting forth the terms and conditions
of a specific Award.

 

(g)          
“Board” means the Board of Directors of the Company.

 

(h)          
“Cash-Based Award” means an Award denominated in a dollar amount.

 

(i)            
“Cause” means, unless otherwise provided in an Award Agreement, (i) “Cause” as defined in any Individual
Agreement to which the applicable Participant is a party, or (ii) if there is no such Individual Agreement or if it does not define Cause:
(A) the willful or gross neglect by a Participant of his employment duties; (B) the plea of guilty or nolo contendere to, or conviction
for, the commission of a felony offense by a Participant; (C) a material breach by a Participant of a fiduciary duty owed to the Company
or any of its subsidiaries; (D) a material breach by a Participant of any nondisclosure, non-solicitation or non-competition obligation
owed to the Company or any of its Affiliates; (E) a material violation of any of the Company’s “Core Policies,” including
its insider trading and harassment policies; or (F) before a Change in Control, such other events as shall be determined by the Committee
and set forth in a Participant’s Award Agreement. Notwithstanding the general rule of Section 2(c), following a Change in Control,
any determination by the Committee as to whether “Cause” exists shall be subject to de novo review.

 

(j)            
“Change in Control” has the meaning set forth in Section 10(a).

 

     

     

    

 

(k)          
 “Code” means the Internal Revenue Code of 1986, as amended from time to time, and any successor thereto, the
Treasury Regulations thereunder and other relevant interpretive guidance issued by the Internal Revenue Service or the Treasury Department.
Reference to any specific section of the Code shall be deemed to include such regulations and guidance, as well as any successor provision
of the Code.

 

(l)            
“Commission” means the Securities and Exchange Commission or any successor agency.

 

(m)         
“Committee” has the meaning set forth in Section 2(a).

 

(n)          
“Common Stock” means common stock, par value $0.001 per share, of the Company.

 

(o)          
“Company” means Vimeo, Inc., a Delaware corporation, or its successor.

 

(p)          
“Disability” means (i) “Disability” as defined in any Individual Agreement to which the Participant
is a party, or (ii) if there is no such Individual Agreement or it does not define “Disability,” (A) permanent and total
disability as determined under the Company’s long-term disability plan applicable to the Participant, or (B) if there is no such
plan applicable to the Participant or the Committee determines otherwise in an applicable Award Agreement, “Disability” as
determined by the Committee. Notwithstanding the above, with respect to an Incentive Stock Option, Disability shall mean Permanent and
Total Disability as defined in Section 22(e)(3) of the Code and, with respect to all Awards, to the extent required by Section 409A of
the Code, Disability shall mean “disability” within the meaning of Section 409A of the Code.

 

(q)          
“Disaffiliation” means a Subsidiary’s or Affiliate’s ceasing to be a Subsidiary or Affiliate for
any reason (including, without limitation, as a result of a public offering, or a spinoff or sale by the Company, of the stock of the
Subsidiary or Affiliate) or a sale of a division of the Company and its Affiliates.

 

(r)            
“Eligible Individuals” means directors, officers, employees and consultants of the Company or any of its Subsidiaries
or Affiliates, and prospective directors, officers, employees and consultants who have accepted offers of employment or consultancy from
the Company or its Subsidiaries or Affiliates.

 

(s)           
“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, and any successor thereto.

 

(t)            
“Fair Market Value” means, unless otherwise determined by the Committee, the closing price of a share of Common
Stock on the Applicable Exchange on the date of measurement, or if Shares were not traded on the Applicable Exchange on such measurement
date, then on the next preceding date on which Shares were traded, all as reported by such source as the Committee may select. If the
Common Stock is not listed on a national securities exchange, Fair Market Value shall be determined by the Committee in its good faith
discretion, provided that such determination shall be made in a manner consistent with any applicable requirements of Section 409A of
the Code.

 

(u)          
“Free-Standing SAR” has the meaning set forth in Section 5(b).

 

(v)          
“Grant Date” means (i) the date on which the Committee by resolution selects an Eligible Individual to receive
a grant of an Award and determines the number of Shares to be subject to such Award or the formula for earning a number of shares or cash
amount, (ii) such later date as the Committee shall provide in such resolution, and (iii) the initial date on which a Adjusted Award was
granted by IAC or Vimeo.com, Inc. (f/k/a Vimeo, Inc.), as applicable.

 

(w)         
“IAC” means IAC/InterActiveCorp, a Delaware corporation.

 

    -2- 

     

    

 

(x)          
 “Incentive Stock Option” means any Option that is designated in the applicable Award Agreement as an “incentive
stock option” within the meaning of Section 422 of the Code, and that in fact so qualifies.

 

(y)          
“Individual Agreement” means an employment, consulting or similar agreement between a Participant and the Company
or one of its Subsidiaries or Affiliates.

 

(z)           
“NASDAQ” means the National Association of Securities Dealers Inc. Automated Quotation System.

 

(aa)        
“Nonqualified Option” means any Option that is not an Incentive Stock Option.

 

(bb)       
“Option” means an Award described under Section 5.

 

(cc)        
“Participant” means an Eligible Individual to whom an Award is or has been granted.

 

(dd)       
“Permitted Holders” means any one or more of (i) Barry Diller, (ii) each of the respective Affiliated Persons
of Barry Diller and (iii) any Person a majority of the aggregate voting power of all the outstanding classes or series of the equity securities
of which are beneficially owned by any one or more of the Persons referred to in clauses (i) or (ii).

 

(ee)        
“Performance Goals” means the performance goals established by the Committee in connection with the grant of
an Award.

 

(ff)         
“Person” means any individual, corporation, partnership, limited liability company, joint venture, incorporated
or unincorporated association, joint-stock company, trust, unincorporated organization or government or other agency or political subdivision
thereof or other entity of any kind.

 

(gg)       
“Plan” means this Vimeo, Inc. 2021 Stock and Annual Incentive Plan, as set forth herein and as hereafter amended
from time to time.

 

(hh)       
“Restricted Stock” means an Award described under Section 6.

 

(ii)          
“Restricted Stock Units” means an Award described under Section 7.

 

(jj)          
“Retirement” means retirement from active employment with the Company, a Subsidiary or Affiliate at or after
the Participant’s attainment of age 65.

 

(kk)       
“RS Restriction Period” has the meaning set forth in Section 6(b)(ii).

 

(ll)          
“RSU Restriction Period” has the meaning set forth in Section 7(b)(ii).

 

(mm)   
“Share” means a share of Common Stock.

 

(nn)       
“Stock Appreciation Right” has the meaning set forth in Section 5(b).

 

(oo)       
“Subsidiary” means any corporation, partnership, joint venture, limited liability company or other entity during
any period in which at least a 50% voting or profits interest is owned, directly or indirectly, by the Company or any successor to the
Company.

 

(pp)       
“Tandem SAR” has the meaning set forth in Section 5(b).

 

(qq)       
“Term” means the maximum period during which an Option or Stock Appreciation Right may remain outstanding, subject
to earlier termination upon Termination of Employment or otherwise, as specified in the applicable Award Agreement.

 

    -3- 

     

    

 

(rr)         
 “Termination of Employment” means the termination of the applicable Participant’s employment with, or
performance of services for, the Company and any of its Subsidiaries or Affiliates. Unless otherwise determined by the Committee, if a
Participant’s employment with, or membership on a board of directors of, the Company and its Affiliates terminates but such Participant
continues to provide services to the Company and its Affiliates in a non-employee director capacity or as an employee, as applicable,
such change in status shall not be deemed a Termination of Employment. A Participant employed by, or performing services for, a Subsidiary
or an Affiliate or a division of the Company and its Affiliates shall be deemed to incur a Termination of Employment if, as a result of
a Disaffiliation, such Subsidiary, Affiliate, or division ceases to be a Subsidiary, Affiliate or division, as the case may be, and the
Participant does not immediately thereafter become an employee of (or service provider for), or member of the board of directors of, the
Company or another Subsidiary or Affiliate. Temporary absences from employment because of illness, vacation or leave of absence and transfers
among the Company and its Subsidiaries and Affiliates shall not be considered Terminations of Employment. Notwithstanding the foregoing,
with respect to any Award that constitutes “nonqualified deferred compensation” within the meaning of Section 409A of the
Code, “Termination of Employment” shall mean a “separation from service” as defined under Section 409A of the
Code.

 

Section
2.           
ADMINISTRATION

 

(a)    
Committee. The Plan shall be administered by the Compensation and Human Resources Committee of the Board or such other
committee of the Board as the Board may from time to time designate (the “Committee”), which committee shall be composed
of not less than two directors, and shall be appointed by and serve at the pleasure of the Board. The Committee shall, subject to Section
11, have plenary authority to grant Awards pursuant to the terms of the Plan to Eligible Individuals. Among other things, the Committee
shall have the authority, subject to the terms of the Plan:

 

(i)      
to select the Eligible Individuals to whom Awards may from time to time be granted;

 

(ii)      
to determine whether and to what extent Incentive Stock Options, Nonqualified Options, Stock Appreciation Rights, Restricted
Stock, Restricted Stock Units, other stock-based awards, Cash-Based Awards or any combination thereof, are to be granted hereunder;

 

(iii)      
to determine the number of Shares to be covered by each Award granted hereunder or the amount of any Cash-Based Award;

 

(iv)      
to determine the terms and conditions of each Award granted hereunder, based on such factors as the Committee shall determine;

 

(v)      
subject to Section 12, to modify, amend or adjust the terms and conditions of any Award, at any time or from time to time;

 

(vi)      
to adopt, alter and repeal such administrative rules, guidelines and practices governing the Plan as it shall from time
to time deem advisable;

 

(vii)      
to accelerate the vesting or lapse of restrictions of any outstanding Award, based in each case on such considerations as
the Committee in its sole discretion determines;

 

(viii)      
to interpret the terms and provisions of the Plan and any Award issued under the Plan (and any agreement relating thereto);

 

(ix)      
to establish any “blackout” period that the Committee in its sole discretion deems necessary or advisable;

 

(x)      
to decide all other matters that must be determined in connection with an Award; and

 

    -4- 

     

    

 

(xi)      
 to otherwise administer the Plan.

 

(b)   
Procedures. (i) The Committee may act only by a majority of its members then in office, except that the Committee may,
except to the extent prohibited by applicable law or the listing standards of the Applicable Exchange and subject to Section 11, allocate
all or any portion of its responsibilities and powers to any one or more of its members and may delegate all or any part of its responsibilities
and powers to any person or persons selected by it.

 

(ii)      
Any authority granted to the Committee may also be exercised by the full Board. To the extent that any permitted action
taken by the Board conflicts with action taken by the Committee, the Board action shall control.

 

(c)    
Discretion of Committee. Subject to Section 1(i), any determination made by the Committee or by an appropriately delegated
officer pursuant to delegated authority under the provisions of the Plan with respect to any Award shall be made in the sole discretion
of the Committee or such delegate at the time of the grant of the Award or, unless in contravention of any express term of the Plan,
at any time thereafter. All decisions made by the Committee or any appropriately delegated officer pursuant to the provisions of the
Plan shall be final and binding on all persons, including the Company, Participants, and Eligible Individuals.

 

(d)   
Award Agreements. The terms and conditions of each Award (other than any Cash-Based Award), as determined by the Committee,
shall be set forth in an Award Agreement, which shall be delivered to the Participant receiving such Award upon, or as promptly as is
reasonably practicable following, the grant of such Award. The effectiveness of an Award shall not be subject to the Award Agreement’s
being signed by the Company and/or the Participant receiving the Award unless specifically so provided in the Award Agreement. Award
Agreements may be amended only in accordance with Section 12 hereof.

 

Section
3.           
COMMON STOCK SUBJECT TO PLAN

 

(a)    
Plan Maximums. The maximum number of Shares that may be delivered pursuant to Awards under the Plan shall be the sum
of (i) the number of Shares that may be issuable upon exercise, vesting or settlement of Adjusted Awards and (ii) 10,000,000. The maximum
number of Shares that may be granted pursuant to Options intended to be Incentive Stock Options shall be 10,000,000 Shares. Shares subject
to an Award under the Plan may be authorized and unissued Shares or may be treasury Shares.

 

(b)   
Individual Limits. During a calendar year, no single Participant (excluding non-employee directors of the Company)
may be granted:

 

(i)      
Options or Stock Appreciation Rights covering in excess of 3,000,000 Shares in the aggregate; or

 

(ii)      
Restricted Stock, Restricted Stock Units or other stock-based awards (other than Options or Stock Appreciation Rights) covering
in excess of 2,000,000 Shares in the aggregate.

 

(c)    
Rules for Calculating Shares Delivered.

 

(i)      
With respect to Awards other than Adjusted Awards, to the extent that any Award is forfeited, terminates, expires or lapses
without being exercised, or any Award is settled for cash, the Shares subject to such Award not delivered as a result thereof shall again
be available for Awards under the Plan.

 

(ii)      
With respect to Awards other than Adjusted Awards, if the exercise price of any Option and/or the tax withholding obligations
relating to any Award are satisfied by delivering Shares to the Company (by either actual delivery or by attestation), only the number
of Shares issued net of the Shares delivered or attested to shall be deemed delivered for purposes of the limits set forth in Section
3(a).

 

    -5- 

     

    

 

(iii)      
 With respect to Awards other than Adjusted Awards, to the extent any Shares subject to an Award are withheld to satisfy
the exercise price (in the case of an Option) and/or the tax withholding obligations relating to such Award, such Shares shall not be
deemed to have been delivered for purposes of the limits set forth in Section 3(a).

 

(d)   
Adjustment Provisions.

 

(i)      
In the event of a merger, consolidation, acquisition of property or shares, stock rights offering, liquidation, Disaffiliation
(other than a spinoff), or similar event affecting the Company or any of its Subsidiaries (each, a “Corporate Transaction”),
the Committee or the Board may in its discretion make such substitutions or adjustments as it deems appropriate and equitable to (A) the
aggregate number and kind of Shares or other securities reserved for issuance and delivery under the Plan, (B) the various maximum limitations
set forth in Sections 3(a) and 3(b) upon certain types of Awards and upon the grants to individuals of certain types of Awards, (C) the
number and kind of Shares or other securities subject to outstanding Awards; and (D) the exercise price of outstanding Options and Stock
Appreciation Rights.

 

(ii)      
In the event of a stock dividend, stock split, reverse stock split, separation, spinoff, reorganization, extraordinary dividend
of cash or other property, share combination, or recapitalization or similar event affecting the capital structure of the Company (each,
a “Share Change”), the Committee or the Board shall make such substitutions or adjustments as it deems appropriate
and equitable to (A) the aggregate number and kind of Shares or other securities reserved for issuance and delivery under the Plan, (B)
the various maximum limitations set forth in Sections 3(a) and 3(b) upon certain types of Awards and upon the grants to individuals of
certain types of Awards, (C) the number and kind of Shares or other securities subject to outstanding Awards; and (D) the exercise price
of outstanding Options and Stock Appreciation Rights.

 

(iii)      
In the case of Corporate Transactions, the adjustments contemplated by clause (i) of this paragraph (d) may include, without
limitation, (A) the cancellation of outstanding Awards in exchange for payments of cash, property or a combination thereof having an aggregate
value equal to the value of such Awards, as determined by the Committee or the Board in its sole discretion (it being understood that
in the case of a Corporate Transaction with respect to which holders of Common Stock receive consideration other than publicly traded
equity securities of the ultimate surviving entity, any such determination by the Committee that the value of an Option or Stock Appreciation
Right shall for this purpose be deemed to equal the excess, if any, of the value of the consideration being paid for each Share pursuant
to such Corporate Transaction over the exercise price of such Option or Stock Appreciation Right shall conclusively be deemed valid);
(B) the substitution of other property (including, without limitation, cash or other securities of the Company and securities of entities
other than the Company) for the Shares subject to outstanding Awards; and (C) in connection with any Disaffiliation, arranging for the
assumption of Awards, or replacement of Awards with new awards based on other property or other securities (including, without limitation,
other securities of the Company and securities of entities other than the Company), by the affected Subsidiary, Affiliate, or division
or by the entity that controls such Subsidiary, Affiliate, or division following such Disaffiliation (as well as any corresponding adjustments
to Awards that remain based upon Company securities). The Committee may adjust the Performance Goals applicable to any Awards to reflect
any Share Change and any Corporate Transaction and any unusual or non-recurring events and other extraordinary items, impact of charges
for restructurings, discontinued operations, and the cumulative effects of accounting or tax changes, each as defined by generally accepted
accounting principles or as identified in the Company’s financial statements, notes to the financial statements, management’s
discussion and analysis or the Company’s other filings with the Commission. Any adjustments made pursuant to this Section 3(d) to
Awards that are considered “deferred compensation” within the meaning of Section 409A of the Code shall be made in compliance
with the requirements of Section 409A of the Code. Any adjustments made pursuant to this Section 3(d) to Awards that are not considered
 “deferred compensation” subject to Section 409A of the Code shall be made in such a manner as to ensure that after such adjustment,
the Awards either (A) continue not to be subject to Section 409A of the Code or (B) comply with the requirements of Section 409A of the
Code.

 

(iv)      
Any adjustment under this Section 3(d) need not be the same for all Participants.

 

    -6- 

     

    

 

Section
4.           
ELIGIBILITY

 

Awards may be granted under the Plan to Eligible
Individuals; provided, however, that Incentive Stock Options may be granted only to employees of the Company and its subsidiaries
or parent corporation (within the meaning of Section 424(f) of the Code).

 

Section
5.           
OPTIONS AND STOCK APPRECIATION RIGHTS

 

With respect to Adjusted Awards, the provisions
below will be applicable only to the extent that they are not inconsistent with the terms of the applicable Adjusted Award.

 

(a)    
Types of Options. Options may be of two types: Incentive Stock Options and Nonqualified Options. The Award Agreement
for an Option shall indicate whether the Option is intended to be an Incentive Stock Option or a Nonqualified Option.

 

(b)   
Types and Nature of Stock Appreciation Rights. Stock Appreciation Rights may be “Tandem SARs,” which are
granted in conjunction with an Option, or “Free-Standing SARs,” which are not granted in conjunction with an Option. Upon
the exercise of a Stock Appreciation Right, the Participant shall be entitled to receive an amount in cash, Shares, or both, in value
equal to the product of (i) the excess of the Fair Market Value of one Share over the exercise price of the applicable Stock Appreciation
Right, multiplied by (ii) the number of Shares in respect of which the Stock Appreciation Right has been exercised. The applicable Award
Agreement shall specify whether such payment is to be made in cash or Common Stock or both, or shall reserve to the Committee or the
Participant the right to make that determination prior to or upon the exercise of the Stock Appreciation Right.

 

(c)    
Tandem SARs. A Tandem SAR may be granted at the Grant Date of the related Option. A Tandem SAR shall be exercisable
only at such time or times and to the extent that the related Option is exercisable in accordance with the provisions of this Section
5, and shall have the same exercise price as the related Option. A Tandem SAR shall terminate or be forfeited upon the exercise or forfeiture
of the related Option, and the related Option shall terminate or be forfeited upon the exercise or forfeiture of the Tandem SAR.

 

(d)   
Exercise Price. The exercise price per Share subject to an Option or Stock Appreciation Right shall be determined by
the Committee and set forth in the applicable Award Agreement, and shall not be less than the Fair Market Value of a share of the Common
Stock on the applicable Grant Date. In no event may any Option or Stock Appreciation Right granted under this Plan be amended, other
than pursuant to Section 3(d), to decrease the exercise price thereof, be cancelled in exchange for cash or other Awards or in conjunction
with the grant of any new Option or Stock Appreciation Right with a lower exercise price or otherwise be subject to any action that would
be treated under the Applicable Exchange listing standards or for accounting purposes, as a “repricing” of such Option or
Stock Appreciation Right, unless such amendment, cancellation, or action is approved by the Company’s stockholders.

 

(e)    
Term. The Term of each Option and each Stock Appreciation Right shall be fixed by the Committee, but shall not exceed
ten years from the Grant Date.

 

(f)     
Vesting and Exercisability. Except as otherwise provided herein, Options and Stock Appreciation Rights shall be exercisable
at such time or times and subject to such terms and conditions as shall be determined by the Committee. If the Committee provides that
any Option or Stock Appreciation Right will become exercisable only in installments, the Committee may at any time waive such installment
exercise provisions, in whole or in part, based on such factors as the Committee may determine. In addition, the Committee may at any
time accelerate the exercisability of any Option or Stock Appreciation Right.

 

    -7- 

     

    

 

(g)   
Method of Exercise. Subject to the provisions of this Section 5, Options and Stock Appreciation Rights may be exercised,
in whole or in part, at any time during the applicable Term by giving written notice of exercise to the Company or through the procedures
established with the Company’s appointed third-party Plan administrator specifying the number of Shares as to which the Option
or Stock Appreciation Right is being exercised; provided, however, that, unless otherwise permitted by the Committee, any
such exercise must be with respect to a portion of the applicable Option or Stock Appreciation Right relating to no less than the lesser
of the number of Shares then subject to such Option or Stock Appreciation Right or 100 Shares. In the case of the exercise of an Option,
such notice shall be accompanied by payment in full of the aggregate purchase price (which shall equal the product of such number of
Shares subject to such Option multiplied by the applicable per Share exercise price) by certified or bank check or such other instrument
as the Company may accept. If approved by the Committee, payment, in full or in part, may also be made as follows:

 

(i)      
Payment may be made in the form of unrestricted Shares already owned by Participant (by delivery of such Shares or by attestation)
of the same class as the Common Stock subject to the Option (based on the Fair Market Value of the Common Stock on the date the Option
is exercised); provided, however, that, in the case of an Incentive Stock Option, the right to make a payment in the form
of already owned Shares of the same class as the Common Stock subject to the Option may be authorized only at the time the Option is granted.

 

(ii)      
To the extent permitted by applicable law, payment may be made by delivering a properly executed exercise notice to the
Company, together with a copy of irrevocable instructions to a broker to deliver promptly to the Company the amount of sale proceeds necessary
to pay the purchase price, and, if requested, the amount of any federal, state, local or foreign withholding taxes. To facilitate the
foregoing, the Company may, to the extent permitted by applicable law, enter into agreements for coordinated procedures with one or more
brokerage firms. To the extent permitted by applicable law, the Committee may also provide for Company loans to be made for purposes of
the exercise of Options.

 

(iii)      
Payment may be made by instructing the Company to withhold a number of Shares having a Fair Market Value (based on the Fair
Market Value of the Common Stock on the date the applicable Option is exercised) equal to the product of (A) the exercise price per Share
multiplied by (B) the number of Shares in respect of which the Option shall have been exercised.

 

(h)   
Delivery; Rights of Stockholders. No Shares shall be delivered pursuant to the exercise of an Option until the exercise
price therefor has been fully paid and applicable taxes have been withheld. The applicable Participant shall have all of the rights of
a stockholder of the Company holding the class or series of Common Stock that is subject to the Option or Stock Appreciation Right (including,
if applicable, the right to vote the applicable Shares and the right to receive dividends), when the Participant (i) has given written
notice of exercise, (ii) if requested, has given the representation described in Section 14(a), and (iii) in the case of an Option, has
paid in full for such Shares.

 

(i)     
Terminations of Employment. Subject to Section 10(b), a Participant’s Options and Stock Appreciation Rights shall
be forfeited upon such Participant’s Termination of Employment, except as set forth below:

 

(i)      
Upon a Participant’s Termination of Employment by reason of death, any Option or Stock Appreciation Right held by
the Participant that was exercisable immediately before the Termination of Employment may be exercised at any time until the earlier of
(A) the first anniversary of the date of such death and (B) the expiration of the Term thereof;

 

(ii)      
Upon a Participant’s Termination of Employment by reason of Disability or Retirement, any Option or Stock Appreciation
Right held by the Participant that was exercisable immediately before the Termination of Employment may be exercised at any time until
the earlier of (A) the first anniversary of such Termination of Employment and (B) the expiration of the Term thereof;

 

(iii)      
Upon a Participant’s Termination of Employment for Cause, any Option or Stock Appreciation Right held by the Participant
shall be forfeited, effective as of such Termination of Employment;

 

(iv)       Upon
a Participant’s Termination of Employment for any reason other than death, Disability, Retirement or for Cause, any Option or
Stock Appreciation Right held by the Participant that was exercisable immediately before the Termination of Employment may be
exercised at any time until the earlier of (A) the 90th day following such Termination of Employment and (B) expiration of the Term
thereof; and

 

    -8- 

     

    

 

(v)      
Notwithstanding the above provisions of this Section 5(i), if a Participant dies after such Participant’s Termination
of Employment but while any Option or Stock Appreciation Right remains exercisable as set forth above, such Option or Stock Appreciation
Right may be exercised at any time until the later of (A) the earlier of (1) the first anniversary of the date of such death and (2) expiration
of the Term thereof and (B) the last date on which such Option or Stock Appreciation Right would have been exercisable, absent this Section
5(i)(v).

 

Notwithstanding the foregoing, the Committee shall have the power,
in its discretion, to apply different rules concerning the consequences of a Termination of Employment; provided, however,
that if such rules are less favorable to the Participant than those set forth above, such rules are set forth in the applicable Award
Agreement. If an Incentive Stock Option is exercised after the expiration of the exercise periods that apply for purposes of Section 422
of the Code, such Option will thereafter be treated as a Nonqualified Option.

 

(j)     
Nontransferability of Options and Stock Appreciation Rights. No Option or Stock Appreciation Right shall be transferable
by a Participant other than (i) by will or by the laws of descent and distribution, or (ii) in the case of a Nonqualified Option or Stock
Appreciation Right, pursuant to a qualified domestic relations order or as otherwise expressly permitted by the Committee including,
if so permitted, pursuant to a transfer to the Participant’s family members or to a charitable organization, whether directly or
indirectly or by means of a trust or partnership or otherwise. For purposes of this Plan, unless otherwise determined by the Committee,
 “family member” shall have the meaning given to such term in General Instructions A.1(a)(5) to Form S-8 under the Securities
Act of 1933, as amended, and any successor thereto. A Tandem SAR shall be transferable only with the related Option as permitted by the
preceding sentence. Any Option or Stock Appreciation Right shall be exercisable, subject to the terms of this Plan, only by the applicable
Participant, the guardian or legal representative of such Participant, or any person to whom such Option or Stock Appreciation Right
is permissibly transferred pursuant to this Section 5(j), it being understood that the term “Participant” includes such guardian,
legal representative and other transferee; provided, however, that the term “Termination of Employment” shall
continue to refer to the Termination of Employment of the original Participant.

 

Section
6.           
RESTRICTED STOCK

 

With respect to Adjusted Awards, the provisions
below will be applicable only to the extent that they are not inconsistent with the terms of the applicable Adjusted Award.

 

(a)    
Nature of Awards and Certificates. Shares of Restricted Stock are actual Shares issued to a Participant, and shall
be evidenced in such manner as the Committee may deem appropriate, including book-entry registration or issuance of one or more stock
certificates. Any certificate issued in respect of Shares of Restricted Stock shall be registered in the name of the applicable Participant
and shall bear an appropriate legend referring to the terms, conditions, and restrictions applicable to such Award, substantially in
the following form:

 

“The transferability of this certificate and the shares
of stock represented hereby are subject to the terms and conditions (including forfeiture) of the Vimeo, Inc. 2021 Stock and Annual Incentive
Plan and an Award Agreement. Copies of such Plan and Agreement are on file at the offices of Vimeo, Inc.”

 

The Committee may require that the certificates evidencing such shares
be held in custody by the Company until the restrictions thereon shall have lapsed and that, as a condition of any Award of Restricted
Stock, the applicable Participant shall have delivered a stock power, endorsed in blank, relating to the Common Stock covered by such
Award.

 

(b)   
Terms and Conditions. Shares of Restricted Stock shall be subject to the following terms and conditions:

 

(i)       The
Committee shall, prior to or at the time of grant, condition the vesting or transferability of an Award of Restricted Stock upon the
continued service of the applicable Participant or the attainment of Performance Goals, or the attainment of Performance Goals and
the continued service of the applicable Participant. The conditions for grant, vesting, or transferability and the other provisions
of Restricted Stock Awards (including without limitation any Performance Goals) need not be the same with respect to each
Participant.

 

    -9- 

     

    

 

(ii)      
Subject to the provisions of the Plan and the applicable Award Agreement, so long as a Restricted Stock Award remains subject
to the satisfaction of vesting conditions (the “RS Restriction Period”), the Participant shall not be permitted to
sell, assign, transfer, pledge or otherwise encumber Shares of Restricted Stock.

 

(iii)      
Except as provided in this Section 6 and in the applicable Award Agreement, the applicable Participant shall have, with
respect to the Shares of Restricted Stock, all of the rights of a stockholder of the Company holding the class or series of Common Stock
that is the subject of the Restricted Stock, including, if applicable, the right to vote the Shares and the right to receive any cash
dividends. If so determined by the Committee in the applicable Award Agreement and subject to Section 14(e), (A) cash dividends on the
class or series of Common Stock that is the subject of the Restricted Stock Award shall be automatically reinvested in additional Restricted
Stock, held subject to the vesting of the underlying Restricted Stock, and (B) subject to any adjustment pursuant to Section 3(d), dividends
payable in Common Stock shall be paid in the form of Restricted Stock of the same class as the Common Stock with which such dividend was
paid, held subject to the vesting of the underlying Restricted Stock.

 

(iv)      
Except as otherwise set forth in the applicable Award Agreement and subject to Section 10(b), upon a Participant’s
Termination of Employment for any reason during the RS Restriction Period or before the applicable Performance Goals are satisfied, all
Shares of Restricted Stock still subject to restriction shall be forfeited by such Participant; provided, however, that
the Committee shall have the discretion to waive, in whole or in part, any or all remaining restrictions with respect to any or all of
such Participant’s Shares of Restricted Stock.

 

(v)      
If and when any applicable Performance Goals are satisfied and the RS Restriction Period expires without a prior forfeiture
of the Shares of Restricted Stock for which legended certificates have been issued, unlegended certificates for such Shares shall be delivered
to the Participant upon surrender of the legended certificates.

 

Section
7.           
RESTRICTED STOCK UNITS

 

With respect to Adjusted Awards, the provisions
below will be applicable only to the extent that they are not inconsistent with the terms of the applicable Adjusted Award.

 

(a)    
Nature of Awards. Restricted Stock Units are Awards denominated in Shares that will be settled, subject to the terms
and conditions of the Restricted Stock Units, in an amount in cash, Shares or both, based upon the Fair Market Value of a specified number
of Shares.

 

(b)   
Terms and Conditions. Restricted Stock Units shall be subject to the following terms and conditions:

 

(i)      
The Committee shall, prior to or at the time of grant, condition the grant, vesting, or transferability of Restricted Stock
Units upon the continued service of the applicable Participant or the attainment of Performance Goals, or the attainment of Performance
Goals and the continued service of the applicable Participant. The conditions for grant, vesting or transferability and the other provisions
of Restricted Stock Units (including without limitation any Performance Goals) need not be the same with respect to each Participant.

 

(ii)      
Subject to the provisions of the Plan and the applicable Award Agreement, so long as an Award of Restricted Stock Units
remains subject to the satisfaction of vesting conditions (the “RSU Restriction Period”), the Participant shall not
be permitted to sell, assign, transfer, pledge or otherwise encumber Restricted Stock Units.

 

    -10- 

     

    

 

(iii)      
 The Award Agreement for Restricted Stock Units shall specify whether, to what extent and on what terms and conditions the
applicable Participant shall be entitled to receive current or delayed payments of cash, Common Stock or other property corresponding
to the dividends payable on the Common Stock (subject to Section 14(e) below).

 

(iv)      
Except as otherwise set forth in the applicable Award Agreement, and subject to Section 10(b), upon a Participant’s
Termination of Employment for any reason during the RSU Restriction Period or before the applicable Performance Goals are satisfied, all
Restricted Stock Units still subject to restriction shall be forfeited by such Participant; provided, however, that the
Committee shall have the discretion to waive, in whole or in part, any or all remaining restrictions with respect to any or all of such
Participant’s Restricted Stock Units.

 

(v)      
Except to the extent otherwise provided in the applicable Award Agreement, an award of Restricted Stock Units shall be settled
as and when the Restricted Stock Units vest (but in no event later than March 15 of the calendar year following the end of the calendar
year in which the Restricted Stock Units vest).

 

Section
8.           
OTHER STOCK-BASED AWARDS

 

Other Awards of Common Stock and other Awards
that are valued in whole or in part by reference to, or are otherwise based upon or settled in, Common Stock, including (without limitation),
unrestricted stock, performance units, dividend equivalents, and convertible debentures, may be granted under the Plan.

 

Section
9.           
CASH-BASED AWARDS

 

Cash-Based Awards may be granted under this Plan.
Cash-Based Awards may be paid in cash or in Shares (valued at Fair Market Value as of the date of payment) as determined by the Committee.

 

Section
10.        CHANGE
IN CONTROL PROVISIONS

 

(a)    
Definition of Change in Control. Except as otherwise may be provided in an applicable Award Agreement, for purposes
of the Plan, a “Change in Control” shall mean any of the following events:

 

(i)      
The acquisition by any individual entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act),
other than a Permitted Holder, of beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of equity
securities of the Company representing more than 50% of the voting power of the then outstanding equity securities of the Company entitled
to vote generally in the election of directors (the “Outstanding Company Voting Securities”); provided, however,
that for purposes of this subsection (i), the following acquisitions shall not constitute a Change in Control: (A) any acquisition by
the Company, (B) any acquisition directly from the Company, (C) any acquisition by any employee benefit plan (or related trust) sponsored
or maintained by the Company or any corporation controlled by the Company, or (D) any acquisition pursuant to a transaction which complies
with clauses (A), (B) and (C) of subsection (iii); or

 

(ii)      
Individuals who, as of the Effective Date, constitute the Board (the “Incumbent Board”) cease for any
reason to constitute at least a majority of the Board; provided, however, that any individual becoming a director subsequent
to the Effective Date, whose election, or nomination for election by the Company’s stockholders, was approved by a vote of at least
a majority of the directors then comprising the Incumbent Board shall be considered as though such individual were a member of the Incumbent
Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of an actual or threatened
election contest with respect to the election or removal of directors or other actual or threatened solicitation of proxies or consents
by or on behalf of a Person other than the Board; or

 

    -11- 

     

    

 

(iii)       Consummation
of a reorganization, merger or consolidation or sale or other disposition of all or substantially all of the assets of the Company
or the purchase of assets or stock of another entity (a “Business Combination”), in each case, unless immediately
following such Business Combination, (A) all or substantially all of the individuals and entities who were the beneficial owners of
the Outstanding Company Voting Securities immediately prior to such Business Combination will beneficially own, directly or
indirectly, more than 50% of the then outstanding combined voting power of the then outstanding voting securities entitled to vote
generally in the election of directors (or equivalent governing body, if applicable) of the entity resulting from such Business
Combination (including, without limitation, an entity which as a result of such transaction owns the Company or all or substantially
all of the Company’s assets either directly or through one or more subsidiaries) in substantially the same proportions as
their ownership, immediately prior to such Business Combination of the Outstanding Company Voting Securities, (B) no Person
(excluding a Permitted Holder, any employee benefit plan (or related trust) of the Company or such entity resulting from such
Business Combination) will beneficially own, directly or indirectly, more than a majority of the combined voting power of the then
outstanding voting securities of such entity except to the extent that such ownership of the Company existed prior to the Business
Combination and (C) at least a majority of the members of the board of directors (or equivalent governing body, if applicable) of
the entity resulting from such Business Combination will have been members of the Incumbent Board at the time of the initial
agreement, or action of the Board, providing for such Business Combination; or

 

(iv)      
Approval by the stockholders of the Company of a complete liquidation or dissolution of the Company.

 

(b)   
Impact of Event/Double Trigger. Unless otherwise provided in the applicable Award Agreement, subject to Sections 3(d),
10(d) and 14(k), notwithstanding any other provision of this Plan to the contrary, upon a Participant’s Termination of Employment,
during the two-year period following a Change in Control, by the Company other than for Cause or Disability or by the Participant for
Good Reason (as defined below):

 

(i)      
any Options and Stock Appreciation Rights outstanding as of such Termination of Employment which were outstanding as of
the date of such Change in Control shall be fully exercisable and vested and shall remain exercisable until the later of (i) the last
date on which such Option or Stock Appreciation Right would be exercisable in the absence of this Section 10(b) and (ii) the earlier of
(A) the first anniversary of such Change in Control and (B) expiration of the Term of such Option or Stock Appreciation Right;

 

(ii)      
all Restricted Stock outstanding as of such Termination of Employment which were outstanding as of the date of such Change
in Control shall become free of all restrictions and become fully vested and transferable; and

 

(iii)      
all Restricted Stock Units outstanding as of such Termination of Employment which were outstanding as of the date of such
Change in Control shall be considered to be earned and payable in full, and any restrictions shall lapse and such Restricted Stock Units
shall be settled as promptly as is practicable (but in no event later than March 15 of the calendar year following the end of the calendar
year in which the Restricted Stock Units vest).

 

For the avoidance of doubt, a spin-off (or other separation) of the
Company from IAC shall not constitute a Change in Control.

 

(c)     For
purposes of this Section 10, “Good Reason” means (i) “Good Reason”
as defined in any Individual Agreement or Award Agreement to which the applicable Participant is a party, or (ii) if there is no
such Individual Agreement or if it does not define Good Reason, without the Participant’s prior written consent: (A) a
material reduction in the Participant’s rate of annual base salary from the rate of annual base salary in effect for such
Participant immediately prior to the Change in Control, (B) a relocation of the Participant’s principal place of business more
than 35 miles from the city in which such Participant’s principal place of business was located immediately prior to the
Change in Control or (C) a material and demonstrable adverse change in the nature and scope of the Participant’s duties from
those in effect immediately prior to the Change in Control. In order to invoke a Termination of Employment for Good Reason, a
Participant shall provide written notice to the Company of the existence of one or more of the conditions described in clauses (A)
through (C) within 90 days following the Participant’s knowledge of the initial existence of such condition or conditions, and
the Company shall have 30 days following receipt of such written notice (the “Cure Period”)
during which it may remedy the condition. In the event that the Company fails to remedy the condition constituting Good Reason
during the Cure Period, the Participant must terminate employment, if at all, within 90 days following the Cure Period in order for
such Termination of Employment to constitute a Termination of Employment for Good Reason.

 

    -12- 

     

    

 

(d)   
Notwithstanding the foregoing, if any Award is subject to Section 409A of the Code, this Section 10 shall be applicable only to
the extent specifically provided in the Award Agreement or in the Individual Agreement.

 

Section
11.        SECTION
16(b)

 

The provisions of this Plan are intended to ensure
that no transaction under the Plan is subject to (and all such transactions will be exempt from) the short-swing recovery rules of Section
16(b) of the Exchange Act (“Section 16(b)”). Accordingly, the composition of the Committee shall be subject to such
limitations as the Board deems appropriate to permit transactions pursuant to this Plan to be exempt (pursuant to Rule 16b-3 promulgated
under the Exchange Act) from Section 16(b), and no delegation of authority by the Committee shall be permitted if such delegation would
cause any such transaction to be subject to (and not exempt from) Section 16(b).

 

Section
12.        TERM,
AMENDMENT AND TERMINATION

 

(a)    
Effectiveness. The Plan shall be effective as of May 17, 2021 (the “Effective Date”).

 

(b)   
Termination. The Plan will terminate on the tenth anniversary of the Effective Date. Awards outstanding as of such
date shall not be affected or impaired by the termination of the Plan.

 

(c)    
Amendment of Plan. The Board may amend, alter, or discontinue the Plan, but no amendment, alteration or discontinuation
shall be made which would materially impair the rights of the Participant with respect to a previously granted Award without such Participant’s
consent, except such an amendment made to comply with applicable law (including without limitation Section 409A of the Code), stock exchange
rules or accounting rules. In addition, no such amendment shall be made without the approval of the Company’s stockholders to the
extent such approval is required by applicable law or the listing standards of the Applicable Exchange.

 

(d)   
Amendment of Awards. Subject to Section 5(d), the Committee may unilaterally amend the terms of any Award theretofore
granted, but no such amendment shall, without the Participant’s consent, materially impair the rights of any Participant with respect
to an Award, except such an amendment made to cause the Plan or Award to comply with applicable law, stock exchange rules or accounting
rules.

 

Section
13.        UNFUNDED
STATUS OF PLAN

 

It is intended that the Plan constitute an “unfunded”
plan. Solely to the extent permitted under Section 409A, the Committee may authorize the creation of trusts or other arrangements to meet
the obligations created under the Plan to deliver Common Stock or make payments; provided, however, that the existence of
such trusts or other arrangements is consistent with the “unfunded” status of the Plan.

 

Section
14.        GENERAL
PROVISIONS

 

(a)    
Conditions for Issuance. The Committee may require each person purchasing or receiving Shares pursuant to an Award
to represent to and agree with the Company in writing that such person is acquiring the Shares without a view to the distribution thereof.
The certificates for such Shares may include any legend which the Committee deems appropriate to reflect any restrictions on transfer.
Notwithstanding any other provision of the Plan or agreements made pursuant thereto, the Company shall not be required to issue or deliver
any certificate or certificates for Shares under the Plan prior to fulfillment of all of the following conditions: (i) listing or approval
for listing upon notice of issuance, of such Shares on the Applicable Exchange; (ii) any registration or other qualification of such
Shares of the Company under any state or federal law or regulation, or the maintaining in effect of any such registration or other qualification
which the Committee shall, in its absolute discretion upon the advice of counsel, deem necessary or advisable; and (iii) obtaining any
other consent, approval, or permit from any state or federal governmental agency which the Committee shall, in its absolute discretion
after receiving the advice of counsel, determine to be necessary or advisable.

 

    -13- 

     

    

 

(b)   
Additional Compensation Arrangements. Nothing contained in the Plan shall prevent the Company or any Subsidiary or
Affiliate from adopting other or additional compensation arrangements for its employees.

 

(c)    
No Contract of Employment. The Plan shall not constitute a contract of employment, and adoption of the Plan shall not
confer upon any employee any right to continued employment, nor shall it interfere in any way with the right of the Company or any Subsidiary
or Affiliate to terminate the employment of any employee at any time.

 

(d)   
Required Taxes. No later than the date as of which an amount first becomes includible in the gross income of a Participant
for federal, state, local or foreign income or employment or other tax purposes with respect to any Award under the Plan, such Participant
shall pay to the Company, or make arrangements satisfactory to the Company regarding the payment of, any federal, state, local or foreign
taxes of any kind required by law to be withheld with respect to such amount (not to exceed the maximum amount statutorily that is required
by statute to be withheld). If determined by the Company, withholding obligations may be settled with Common Stock, including Common
Stock that is part of the Award that gives rise to the withholding requirement. The obligations of the Company under the Plan shall be
conditional on such payment or arrangements, and the Company and its Affiliates shall, to the extent permitted by law, have the right
to deduct any such taxes from any payment otherwise due to such Participant. The Committee may establish such procedures as it deems
appropriate, including making irrevocable elections, for the settlement of withholding obligations with Common Stock.

 

(e)    
Limitation on Dividend Reinvestment and Dividend Equivalents. Reinvestment of dividends in additional Restricted Stock
at the time of any dividend payment, and the payment of Shares with respect to dividends to Participants holding Awards of Restricted
Stock Units, shall only be permissible if sufficient Shares are available under Section 3 for such reinvestment or payment (taking into
account then outstanding Awards). In the event that sufficient Shares are not available for such reinvestment or payment, such reinvestment
or payment shall be made in the form of a grant of Restricted Stock Units equal in number to the Shares that would have been obtained
by such payment or reinvestment, the terms of which Restricted Stock Units shall provide for settlement in cash and for dividend equivalent
reinvestment in further Restricted Stock Units on the terms contemplated by this Section 14(e).

 

(f)     
Designation of Death Beneficiary. The Committee shall establish such procedures as it deems appropriate for a Participant
to designate a beneficiary to whom any amounts payable in the event of such Participant’s death are to be paid or by whom any rights
of such eligible Individual, after such Participant’s death, may be exercised.

 

(g)   
Subsidiary Employees. In the case of a grant of an Award to any employee of a Subsidiary, the Company may, if the Committee
so directs, issue or transfer the Shares, if any, covered by the Award to the Subsidiary, for such lawful consideration as the Committee
may specify, upon the condition or understanding that the Subsidiary will transfer the Shares to the employee in accordance with the
terms of the Award specified by the Committee pursuant to the provisions of the Plan. All Shares underlying Awards that are forfeited
or canceled shall revert to the Company.

 

(h)   
Governing Law; Venue and Interpretation. The Plan and all Awards made and actions taken thereunder shall be governed
by and construed in accordance with the laws of the State of Delaware, without reference to principles of conflict of laws. Any disputes
arising out of or relating to the Plan or any Award shall be commenced shall be commenced exclusively in the Delaware Court of Chancery
and any state appellate court therefrom within the State of Delaware or, if the Delaware Court of Chancery declines to accept jurisdiction
over a particular matter, any federal or state court of competent jurisdiction located in the State of Delaware. The captions of this
Plan are not part of the provisions hereof and shall have no force or effect.

 

(i)     
Non-Transferability. Except as otherwise provided in Section 5(j) or by the Committee, Awards under the Plan are not
transferable except by will or by laws of descent and distribution.

 

    -14- 

     

    

 

(j)     
Foreign Employees and Foreign Law Considerations. The Committee may grant Awards to Eligible Individuals who are foreign
nationals, who are located outside the United States or who are not compensated from a payroll maintained in the United States, or who
are otherwise subject to (or could cause the Company to be subject to) legal or regulatory provisions of countries or jurisdictions outside
the United States, on such terms and conditions different from those specified in the Plan as may, in the judgment of the Committee,
be necessary or desirable to foster and promote achievement of the purposes of the Plan, and, in furtherance of such purposes, the Committee
may make such modifications, amendments, procedures, or subplans as may be necessary or advisable to comply with such legal or regulatory
provisions.

 

(k)   
Section 409A of the Code. It is the intention of the Company that no Award shall be “deferred compensation”
subject to Section 409A of the Code, unless and to the extent that the Committee specifically determines otherwise as provided in this
Section 14(k), and the Plan and the terms and conditions of all Awards shall be interpreted accordingly. The terms and conditions governing
any Awards that the Committee determines will be subject to Section 409A of the Code, including any rules for elective or mandatory deferral
of the delivery of cash or Shares pursuant thereto and any rules regarding treatment of such Awards in the event of a Change in Control,
shall be set forth in the applicable Award Agreement, and shall comply in all respects with Section 409A of the Code. Notwithstanding
any other provision of the Plan to the contrary, with respect to any Award that constitutes a “nonqualified deferred compensation
plan” subject to Section 409A of the Code, if the Participant is a “specified employee” within the meaning of Section
409A of the Code, any payments (whether in cash, Shares or other property) to be made with respect to the Award upon the Participant’s
Termination of Employment shall be delayed until the earlier of (A) the first day of the seventh month following the Participant’s
Termination of Employment and (B) the Participant’s death. Each payment under any Award shall be treated as a separate payment
for purposes of Section 409A of the Code. In no event may a Participant, directly or indirectly, designate the calendar year of any payment
to be made under any Award.

 

(l)     
Adjusted Awards. Notwithstanding anything in this Plan to the contrary, to the extent that the terms of this Plan are
inconsistent with the terms of an Adjusted Award, the terms of the Adjusted Award shall be governed by the applicable plan under which
the Adjusted Award was granted and the award agreement thereunder (in each case, as amended prior to the occurrence of the separation).
Any reference to a “change in control,” “change of control” or similar definition in an Award Agreement or the
applicable plan for any Adjusted Award shall be deemed to refer to a “change in control,” “change of control”
or similar transaction with respect to the Company (as successor to the originally-referenced entity) for such Adjusted Award.

 

(m)  
Termination for Cause. Notwithstanding anything herein to the contrary, if a Participant
incurs a Termination of Employment for Cause, a Participant resigns in anticipation of being terminated by the Company for Cause or following
any termination of a Participant’s employment with the Company for any reason, the Company becomes aware that during the two (2)
years prior to such Termination of Employment with the Company there was an event or circumstance that would have been grounds for Termination
of Employment for Cause, and the basis of any such termination (x) causes, caused or is reasonable likely to cause significant business
or reputational harm to the Company or any of its Affiliates (as determined in the good faith discretion of the Board) or (y) involves
or involved fraudulent misconduct that relates to or harms the Company or any of its Affiliates (the circumstances of either (x) or (y),
the “Underlying Event”), then (A) all Options and SARs, whether or not vested, and
all other unvested Awards held by such Participant shall be immediately forfeited by the Participant without consideration and cancelled
and (B) if any portion of the Participant’s Awards were exercised and/or settled after the Underlying Event, the Company shall be
entitled to recover from the Participant at any time within two (2) years after such exercise or settlement, and the Participant shall
pay over to the Company, any amounts realized as a result of the exercise or settlement. This remedy shall be without prejudice to, or
waiver of, any other remedies the Company or its subsidiaries or Affiliates may have in such event.

 

    -15-EX-4.2

 Exhibit 4.2 

AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

THIS AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of September 30,
2020, by and among HCW BIOLOGICS INC., a Delaware corporation (the “Company”), and the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”
and collectively referred to as “Investors”. 
 RECITALS 

WHEREAS, the Company and certain of the Investors previously entered into an Amended and Restated Investors’ Rights Agreement
dated as of June 7, 2019 (the “Prior Agreement”); 
 WHEREAS, concurrently with the execution of this
Agreement, the Company and certain of the Investors are entering into a Series C Preferred Stock Purchase Agreement providing for the sale of shares of Series C Preferred Stock (the “Purchase Agreement”); and 

WHEREAS, in order to induce the Company to enter into the Purchase Agreement and to induce Investors to invest funds in the Company
pursuant to the Purchase Agreement, the Investors (having not less than the minimum number of votes necessary) and the Company hereby agree that this Agreement shall amend and restate the Prior Agreement in its entirety and shall govern the rights
of the Investors to receive certain information from the Company, to participate in future equity offerings by the Company, and certain other matters as set forth in this Agreement; 

NOW, THEREFORE, the parties hereby agree as follows: 

1. DEFINITIONS. For purposes of this Agreement: 

“Affiliate” means, with respect to any specified Person, any other Person who, directly or indirectly, controls, is
controlled by, or is under common control with such Person, including without limitation any general partner, managing member, officer, director or trustee of such Person or any venture capital fund or registered investment company now or hereafter
existing that is controlled by one or more general partners, managing members or investment adviser of, or shares the same management company or investment adviser with, such Person. 

“Applicable Securities” means (i) the Common Stock issuable or issued upon conversion of the Preferred Stock;
(ii) any Common Stock, or any Common Stock issued or issuable (directly or indirectly) upon conversion and/or exercise of any other securities of the Company, acquired by the Investors after the date hereof; and (iii) any Common Stock
issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of, the shares referenced in clauses
(i) and (ii) above; excluding in all cases, however, any Applicable Securities sold by a Person in a transaction in which the applicable rights under this Agreement are not assigned pursuant to Section 6.1. 

  
 1 

 “Applicable Securities then Outstanding” means the number of shares
determined by adding the number of shares of outstanding Common Stock that are Applicable Securities and the number of shares of Common Stock issuable (directly or indirectly) pursuant to then exercisable and/or convertible securities that are
Applicable Securities. 
 “Board of Directors” means the board of directors of the Company. 

“Common Stock” means shares of the Company’s Class A Common Stock and Class B Common Stock, each with a
par value of $0.0001 per share. 
 “Certificate of Incorporation” means the Company’s Amended and Restated
Certificate of Incorporation, as amended and/or restated from, time to time. 
 “Derivative Securities” means any
securities or rights convertible into, or exercisable or exchangeable for (in each case, directly or indirectly), Common Stock, including options and warrants. 

“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder. 
 “GAAP” means generally accepted accounting principles in the United States. 

“Holder” means any holder of Applicable Securities who is a party to this Agreement. 

“Immediate Family Member” means a child, stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law,
son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including, adoptive relationships, of a natural person referred to herein. 

“IPO” means the Company’s first underwritten public offering of its Common Stock under the Securities Act. 

“Major Investor” means any Investor that, individually or together with such Investor’s Affiliates, holds at
least 660,000 shares of Applicable Securities (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof). 

“New Securities” means, collectively, equity securities of the Company, whether or not currently authorized, as well
as rights, options, or warrants to purchase such equity securities, or securities of any type whatsoever that are, or may become, convertible or exchangeable into or exercisable for such equity securities. 

“Person” means any individual, corporation, partnership, trust, limited liability company, association or other
entity. 
 “Preferred Holder” means any holder of shares of the Preferred Stock who is a party to this Agreement.

 “Preferred Stock” means Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock. 

  
 2 

 “Requisite Holders” means the holders of at least 66.67% of the
shares of Preferred Stock then outstanding. 
 “Restricted Securities” means the securities of the Company required
to be notated with the legend set forth in Section 2.2(b) hereof. 
 “SEC” means the Securities and Exchange
Commission. 
 “SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act. 

“Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder.

 “Series A Preferred Stock” means shares of the Company’s Series A Preferred Stock, par value $0.0001 per
share. 
 “Series B Preferred Stock” means shares of the Company’s Series B Preferred Stock, par value $0.0001
per share. 
 “Series C Preferred Stock” means shares of the Company’s Series C Preferred Stock, par value
$0.0001 per share. 
 2. LOCK-UP; RESTRICTIONS ON TRANSFER 

2.1 Agreement to Lock-Up. Each Holder hereby agrees that it will not, without the prior written
consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the Company’s initial public offering (the “IPO”) and ending on the date specified by the Company and the
managing underwriter (such period not to exceed 180 days), or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (1) the publication or other distribution of research reports;
and (2) analyst recommendations and opinions, including, but not limited to, the restrictions contained in FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto), (a) lend, offer, pledge, sell,
contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of capital stock held
immediately prior to the effectiveness of the registration statement for the IPO; or (b) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the capital
stock, whether any such transaction described in clause (a) or (b) above is to be settled by delivery of capital stock or other securities, in cash or otherwise. The foregoing provisions of this Section 2.1 shall not apply to the sale
of any shares to an underwriter pursuant to an underwriting agreement, and shall only be applicable to the Holders if all officers, directors and holders of more than one percent (1%) of the outstanding Common Stock (after giving effect to the
conversion into Common Stock of all outstanding Preferred Stock) enter into similar agreements. The underwriters in connection with the IPO are intended third party beneficiaries of this Section 2.1 and shall have the right, power and authority
to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in the IPO that are consistent with this Section 2.1 or that are
necessary to give further effect thereto. 

  
 3 

 2.2 Restrictions on Transfer. 

(a) The Preferred Stock and the Applicable Securities shall not be sold, pledged, or otherwise transferred, and the Company shall not
recognize and shall issue stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon the conditions specified in this Agreement, which conditions are intended to ensure compliance with the
provisions of the Securities Act. A transferring Holder will cause any proposed purchaser, pledgee, or transferee of the Preferred Stock and the Applicable Securities held by such Holder to agree to take and hold such securities subject to the
provisions and upon the conditions specified in this Agreement. 
 (b) Each certificate, instrument, or book entry representing
(i) the Preferred Stock, (ii) the Applicable Securities, and (iii) any other securities issued in respect of the securities referenced in clauses (i) and (ii), upon any stock split, stock dividend, recapitalization, merger,
consolidation, or similar event, shall (unless otherwise permitted by the provisions of Section 2.2(c)) be notated with a legend substantially in the following form: 

THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. SUCH SHARES
MAY NOT BE SOLD, PLEDGED, OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT. 

THE SECURITIES REPRESENTED HEREBY MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER,
A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 
 The Holders consent to the Company making a notation in its records and
giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer set forth in this Section 2.2. 

(c) The holder of such Restricted Securities, by acceptance of ownership thereof, agrees to comply in all respects with the provisions
of this Subsection (c) Before any proposed sale, pledge, or transfer of any Restricted Securities, unless there is in effect a registration statement under the Securities Act covering the proposed transaction, the Holder thereof shall give
notice to the Company of such Holder’s intention to effect such sale, pledge, or transfer. Each such notice shall describe the manner and circumstances of the proposed sale, pledge, or transfer in sufficient detail and, if reasonably requested
by the Company, shall be accompanied at such Holder’s expense by either (i) a written opinion of legal counsel who shall, and whose legal opinion shall, be reasonably satisfactory to the Company, addressed to the Company, to the effect
that the proposed transaction may be effected without registration under the Securities Act; (ii) a “no action” letter from the SEC to the effect that the proposed sale, pledge, or transfer of such Restricted Securities without
registration will not result in a recommendation by the staff of the SEC that action be taken with respect thereto; or (iii) any other evidence reasonably satisfactory to counsel to the Company to the effect that the proposed sale, pledge, or

  
 4 

 
transfer of the Restricted Securities may be effected without registration under the Securities Act, whereupon the Holder of such Restricted Securities shall be entitled to sell, pledge, or
transfer such Restricted Securities in accordance with the terms of the notice given by the Holder to the Company. The Company will not require such a legal opinion or “no action” letter (x) in any transaction in compliance with SEC
Rule 144; or (y) in any transaction in which such Holder distributes Restricted Securities to an Affiliate of such Holder for no consideration; provided that each transferee agrees in writing to be subject to the terms of this
Section 2.2. Each certificate, instrument, or book entry representing the Restricted Securities transferred as above provided shall be notated with, except if such transfer is made pursuant to SEC Rule 144, the appropriate restrictive
legend set forth in Section 2.2(b), except that such certificate instrument, or book entry shall not be notated with such restrictive legend if, in the opinion of counsel for such Holder and the Company, such legend is not required in order to
establish compliance with any provisions of the Securities Act. 
 3. INFORMATION AND OBSERVER RIGHTS. 

3.1 Delivery of Financial Statements. The Company shall deliver or make available, upon request, to each Major Investor, provided
that the Board of Directors has not reasonably determined that such Major Investor is a competitor of the Company: 
 (a) as soon
as practicable, but in any event within 120 days after the end of each fiscal year of the Company (i) a balance sheet as of the end of such year, (ii) statements of income and of cash flows for such year, and (iii) a statement of
stockholders’ equity as of the end of such year; 
 (b) as soon as practicable, but in any event within 45 days after the
end of each of the first three quarters of each fiscal year of the Company, unaudited statements of income and cash flows for such fiscal quarter, and an unaudited balance sheet and a statement of stockholders’ equity as of the end of such
fiscal quarter, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments; and (ii) not contain all notes thereto that may be
required in accordance with GAAP); 
 (c) as soon as practicable, but in any event within forty-five (45) days after the end of
each of the first three (3) quarters of each fiscal year of the Company, (i) a copy of the Company’s summary capitalization table, dated as of the last day of each of the first three quarters of each fiscal year provided that
if the Company has provided access credentials to an online cap table management system for such Major Investors, this requirement shall be deemed satisfied and (ii) a copy of the Company’s most recent 409(a) valuation report; 

(d) such other information relating to the financial condition, business, prospects, or corporate affairs of the Company as any Major
Investor may from time to time reasonably request; provided, however, that the Company shall not be obligated under this Section 3.1 to provide information (i) that the Company reasonably determines in good faith to be a
trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in a form acceptable to the Company); or (ii) the disclosure of which would adversely affect the attorney-client privilege between the Company
and its counsel. 

  
 5 

 If, for any period, the Company has any subsidiary whose accounts are consolidated with
those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries. 

Notwithstanding anything else in this Section 3.1 to the contrary, the Company may cease providing the information set forth in this
Section 3.1 during the period starting with the date 60 days before the Company’s good-faith estimate of the date of filing of a registration statement if it reasonably concludes it must do so to comply with the SEC rules applicable
to such registration statement and related offering; provided that the Company’s covenants under this Section 3.1 shall be reinstated at such time as the Company is no longer actively employing its commercially reasonable efforts to cause
such registration statement to become effective. 
 3.2 Inspection. The Company shall permit each Major Investor (provided
that the Board of Directors has not reasonably determined that such Major Investor is a competitor of the Company), at such Major Investor’s expense, to visit and inspect the Company’s properties; examine its books of account and
records; and discuss the Company’s affairs, finances, and accounts with its officers, during normal business hours of the Company as may be reasonably requested by the Major Investor; provided, however, that the Company shall not
be obligated pursuant to this Section 3.2 to provide access to any information that it reasonably and in good faith considers to be a trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in form
acceptable to the Company) or the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel. 

3.3 Observer Rights. Subject to approval of the Board of Directors, the Company may from time to time invite one or more
representatives of the Investors to attend meetings of its Board of Directors in a nonvoting observer capacity and, in this respect, shall give such representative copies of all notices, minutes, consents, and other materials that it provides to its
directors at the same time and in the same manner as provided to such directors; provided, however, that such representative shall agree to hold in confidence and trust and to act in a fiduciary manner with respect to all information
so provided; and provided further, that the Company reserves the right to withhold any information and to exclude such representative from any meeting or portion thereof if access to such information or attendance at such meeting could
adversely affect the attorney-client privilege between the Company and its counsel or result in disclosure of trade secrets or a conflict of interest, or if such Investor or its representative is a competitor of the Company. 

3.4 Termination of Information and Observer Rights. The covenants set forth in Section 3.1, Section 3.2, and Section 3.3
shall terminate and be of no further force or effect (i) immediately before the consummation of the IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act,
or (iii) upon a Deemed Liquidation Event, as such term is defined in the Certificate of Incorporation, whichever event occurs first. 
  

  
 6 

 3.5 Confidentiality. Each Investor agrees that such Investor will keep confidential
and will not disclose, divulge, or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the Company’s
intention to file a registration statement), unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Section 3.5 by such Investor), (b) is or has been
independently developed or conceived by the Investor without use of the Company’s confidential information, or (c) is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of
confidentiality such third party may have to the Company; provided, however, that an Investor may disclose confidential information (i) to its attorneys, accountants, consultants, and other professionals to the extent necessary to
obtain their services in connection with monitoring its investment in the Company; (ii) to any prospective purchaser of any Applicable Securities from such Investor, if such prospective purchaser agrees to be bound by the provisions of this
Section 3.5; (iii) to any Affiliate, partner, member, stockholder, or wholly owned subsidiary of such Investor in the ordinary course of business, provided that such Investor informs such Person that such information is confidential
and directs such Person to maintain the confidentiality of such information; or (iv) as may otherwise be required by law, provided that the Investor promptly notifies the Company of such disclosure and takes reasonable steps to minimize
the extent of any such required disclosure. 
 4. RIGHTS TO FUTURE STOCK ISSUANCES. 

4.1 Right of First Offer. Subject to the terms and conditions of this Section 4.1 and applicable securities laws, if the Company
proposes to offer or sell any New Securities, the Company shall first offer such New Securities to each Major Investor. A Major Investor shall be entitled to apportion the right of first offer hereby granted to it, in such proportions as it deems
appropriate, among itself and its Affiliates. 
 (a) The Company shall give notice (the “Offer Notice”) to
each Major Investor, stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such New Securities.

 (b) By notification to the Company within 20 days after the Offer Notice is given, each Major Investor may elect to purchase
or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities that equals the proportion that the Common Stock then held by such Major Investor (including all shares of Common Stock then
issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of the Preferred Stock and any other Derivative Securities then held by such Major Investor) bears to the total Common Stock of the Company then outstanding (assuming
full conversion and/or exercise, as applicable, of all Preferred Stock and other Derivative Securities then outstanding). The closing of any sale pursuant to this Section 4.1(b) shall occur within the later of 90 days of the date that the Offer
Notice is given and the date of initial sale of New Securities pursuant to Section 4.1(c). 
 (c) If all New Securities referred
to in the Offer Notice are not elected to be purchased or acquired as provided in Section 4.1(b), the Company may, during the 90 day period following the expiration of the periods provided in Section 4.1(b), offer and sell the remaining
unsubscribed portion of such New Securities to any Person or Persons at a price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice. If 

  
 7 

 
the Company does not enter into an agreement for the sale of the New Securities within such period, or if such agreement is not consummated within 30 days of the execution thereof, the right
provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Major Investors in accordance with this Section 4.1. 

(d) The right of first offer in this Section 4.1 shall not be applicable to (i) Exempted Securities (as defined in the
Company’s Certificate of Incorporation); (ii) shares of Common Stock issued in the IPO; (iii) shares issued in connection with acquisitions made by the Company and (iv) the issuance of shares of Series C Preferred Stock to
Additional Purchasers pursuant to Section 1.3 of the Purchase Agreement. 
 (e) Notwithstanding any provision hereof to the
contrary, in lieu of complying with the provisions of this Section 4.1, the Company may elect to give notice to the Major Investors within 30 days after the issuance of New Securities. Such notice shall describe the type, price, and terms of
the New Securities. Each Major Investor shall have 20 days from the date notice is given to elect to purchase up to the number of New Securities that would, if purchased by such Major Investor, maintain such Major Investor’s
percentage-ownership position, calculated as set forth in Section 4.1(b) before giving effect to the issuance of such New Securities. The closing of such sale shall occur within 60 days of the date notice is given to the Major Investors.

 4.2 Termination. The covenants set forth in Section 4.1 shall terminate and be of no further force or effect
(i) immediately before the consummation of the IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event, as
such term is defined in the Company’s Certificate of Incorporation, whichever event occurs first. 
 5. ADDITIONAL
COVENANTS. 
 5.1 Insurance. The Company will use commercially reasonable efforts to cause its Directors and Officers liability
insurance policy to be maintained until such time as the Board of Directors determines that such insurance should be discontinued. The policy will not be cancelable by the Company without prior approval by the Board of Directors. 

5.2 Employee Agreements. Unless approved by the Board of Directors, the Company will cause each person now or hereafter employed by it
or by any subsidiary (or engaged by the Company or any subsidiary as a consultant/independent contractor) with access to confidential information and/or trade secrets to enter into a nondisclosure and proprietary rights assignment agreement. 

5.3 Successor Indemnification. If the Company or any of its successors or assignees consolidates with or merges into any other Person
and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be made so that the successors and assignees of the Company assume the obligations of the Company with
respect to indemnification of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are contained in the Company’s Bylaws, its Certificate of Incorporation, or elsewhere, as the case may
be. 

  
 8 

 5.4 Board Matters. Unless otherwise determined by the vote of a majority of the
directors then in office, the Board of Directors shall meet at least quarterly in accordance with an agreed-upon schedule. The Company shall reimburse the directors for all reasonable
out-of-pocket travel expenses incurred (consistent with the Company’s travel policy) in connection with attending meetings of the Board of Directors. 

5.5 Termination of Covenants. The covenants set forth in this Section 5, except for Section 5.2, shall terminate and be of no
further force or effect (i) immediately before the consummation of the IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed
Liquidation Event, as such term is defined in the Certificate of Incorporation, whichever event occurs first. 
 6.
MISCELLANEOUS. 
 6.1 Successors and Assigns. The rights under this Agreement may be assigned (but only with all related
obligations) by a Holder to a transferee of Applicable Securities that (i) is an Affiliate of a Holder; (ii) is a Holder’s Immediate Family Member or trust for the benefit of an individual Holder or one or more of such Holder’s
Immediate Family Members; or (iii) after such transfer, holds at least 300,000 shares of Applicable Securities (subject to appropriate adjustment for stock splits, stock dividends, combinations, and other recapitalizations); provided,
however, that (x) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee and the Applicable Securities with respect to which such rights are being
transferred; and (y) such transferee agrees in a written instrument delivered to the Company to be bound by and subject to the terms and conditions of this Agreement, including the provisions of Section 2.1. For the purposes of determining
the number of shares of Applicable Securities held by a transferee, the holdings of a transferee (1) that is an Affiliate or stockholder of a Holder; (2) who is a Holder’s Immediate Family Member; or (3) that is a trust for the
benefit of an individual Holder or such Holder’s Immediate Family Member shall be aggregated together and with those of the transferring Holder; provided further that all transferees who would not qualify individually for assignment of
rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices, or taking any action under this Agreement. The terms and
conditions of this Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties
hereto or their respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided herein. 

6.2 Governing Law. This Agreement shall be governed by the internal law of the State of Delaware, without regard to conflict of law
principles that would result in the application of any law other than the law of the State of Delaware. 
 6.3 Counterparts. This
Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or
any electronic signature complying with the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly
delivered and be valid and effective for all purposes. 

  
 9 

 6.4 Titles and Subtitles. The titles and subtitles used in this Agreement are for
convenience only and are not to be considered in construing or interpreting this Agreement. 
 6.5 Notices. All notices and other
communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or (i) personal delivery to the party to be notified; (ii) when sent, if sent by
electronic mail or facsimile during the recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s next business day; (iii) five days after having been sent by registered or certified
mail, return receipt requested, postage prepaid; or (iv) one business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery,
with written verification of receipt. All communications shall be sent to the respective parties at their addresses as set forth on Schedule A hereto, or to the principal office of the Company and to the attention of the Chief Executive Officer, in
the case of the Company, or to such email address, facsimile number, or address as subsequently modified by written notice given in accordance with this Section 6.5. 

6.6 Amendments and Waivers. Any term of this Agreement may be amended and the observance of any term of this Agreement may be waived
(either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Company and the Requisite Holders; provided that the Company may in its sole discretion waive compliance with
Section 2.2(c) (and the Company’s failure to object promptly in writing after notification of a proposed assignment allegedly in violation of Section 2.2(c) shall be deemed to be a waiver); and provided further that any
provision hereof may be waived by any waiving party on such party’s own behalf, without the consent of any other party. Notwithstanding the foregoing, (a) this Agreement may not be amended or terminated and the observance of any term
hereof may not be waived with respect to any Major Investor without the written consent of such Major Investor, unless such amendment, termination, or waiver applies to all Major Investors in the same fashion (it being agreed that a waiver of the
provisions of Section 4 with respect to a particular transaction shall be deemed to apply to all Major Investors in the same fashion if such waiver does so by its terms, notwithstanding the fact that certain Major Investors may nonetheless, by
agreement with the Company, purchase securities in such transaction) and (b) Sections 3.1 and 3.2, Section 4 and any other section of this Agreement applicable to the Major Investors (including this clause (b) of this
Section 6.6) may not be amended or waived without the written consent of at least a majority of the Applicable Securities then Outstanding held by the Major Investors. The Company shall give prompt notice of any amendment or termination hereof
or waiver hereunder to any party hereto that did not consent in writing to such amendment, termination, or waiver. Any amendment, termination, or waiver effected in accordance with this Section 6.6 shall be binding on all parties hereto,
regardless of whether any such party has consented thereto. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be or construed as a further or continuing waiver of any
such term, condition, or provision. 
 6.7 Severability. In case any one or more of the provisions contained in this Agreement is for
any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such invalid, illegal, or unenforceable provision shall be reformed
and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law. 

  
 10 

 6.8 Aggregation of Stock. All shares of Applicable Securities held or acquired by
Affiliates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among themselves in any manner they deem appropriate. 

6.9 Additional Investors. Notwithstanding anything to the contrary contained herein, if the Company issues additional shares of the
Company’s Series C Preferred Stock after the date hereof, whether pursuant to the Purchase Agreement or otherwise, any purchaser of such shares of Series C Preferred Stock may become a party to this Agreement by executing and delivering an
additional counterpart signature page to this Agreement, and thereafter shall be deemed an “Investor” for all purposes hereunder. No action or consent by the Investors shall be required for such joinder to this Agreement by
such additional Investor, so long as such additional Investor has agreed in writing to be bound by all of the obligations as an “Investor” hereunder. 

6.10 Entire Agreement. This Agreement (including any Schedules and Exhibits hereto) constitutes the full and entire understanding and
agreement among the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled. 

6.11 Jurisdiction; Venue. With respect to any disputes arising out of or related to this Agreement, the parties consent to the
exclusive jurisdiction of, and venue in, the state courts in Broward County in the State of Florida (or in the event of exclusive federal jurisdiction, the courts of the Southern District of Florida). 

6.12 Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party under this Agreement, upon
any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or acquiescence to any such breach or default, or
to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All remedies, whether under this Agreement or by law
or otherwise afforded to any party, shall be cumulative and not alternative. 
 6.13 Acknowledgment. The Company acknowledges that
the Investors are in the business of venture capital investing and therefore review the business plans and related proprietary information of many enterprises, including enterprises that may have products or services that compete directly or
indirectly with those of the Company. Nothing in this Agreement shall preclude or in any way restrict the Investors from investing or participating in any particular enterprise whether or not such enterprise has products or services that compete
with those of the Company. 
 [Remainder of Page Intentionally Left Blank] 

  
 11 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	COMPANY:
	
	HCW BIOLOGICS INC.
		
	By:	 	 /s/ Hing C. Wong

	Name:	 	Hing C. Wong
	Title:	 	Chief Executive Officer
	
	Email: HingWong@hcwbiologics.com

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	INVESTORS:
	
	Dr. Hing C. Wong and Bee Yau Huang
		
	By:	 	 /s/ Hing C. Wong

		
	Name:	 	Dr. Hing C. Wong
		
	By:	 	 /s/ Bee Yau Huang

		
	Name:	 	Bee Yau Huang
	
	Email: hingwong@hcwbiologics.com
		
	Address:	 	2966 Wentworth
		 	Weston, FL 33332

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	INVESTORS:
	
	Golden Triangle Ventures, LLC
		
	By:	 	 /s/ Fred Middleton

		
	Name:	 	Fred A. Middleton
		
	Title:	 	Managing Member
		
	Email:	 	fmiddleton@Sanderling.com
		 	BBloxaham@Sanderling.com
	
	 Address: 400 South El Camino Real, Suite 1200

               San Mateo, CA 94402

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	INVESTORS:
	
	Deepwork HCW Partners LLC
		
	By:	 	 /s/ Mitchel Laskey

		
	Name:	 	Mitchel J. Laskey
		
	Title:	 	Manager
		
	Email:	 	 kathy@deepworkcapital.com

mitchel@deepworkcapital.com

	
	Address: 1030 N. Orange Avenue, Suite 101
	                Orlando, FL 32801

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	INVESTORS:
	
	Loblolly Fund LLC
		
	By:	 	 /s/ John Engels

		
	Name:	 	John Engels
		
	Title:	 	Manager
		
	Email:	 	jpengels@hotmail.com
	
	Address: 824 NW Boulevard
	               Gainesville, FL32601

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	INVESTORS:
	
	Chris Cheung & Ling Cheung
		
	By:	 	 /s/ Chris Cheung

		
	Name:	 	Chris Cheung
		
	By:	 	 /s/ Ling Cheung

		
	Name:	 	Ling Cheung
		
	Email:	 	gucheung29@gmail.com
	
	 Address: 6 Reinsway Circle

              Westford, MA 01886

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	INVESTORS:
	
	Stanley Yu & Winnie Yu
		
	By:	 	 /s/ Stanley Yu

		
	Name:	 	Stanley Yu
		
	By:	 	 /s/ Winnie C. K. Yu

		
	Name:	 	Winnie Yu
	
	Email: Stanley.yu@tpa-food.com
	
	 Address: 9518 Swift Creek Circle

              Dover, FL 33527

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	INVESTORS:
	
	Peter Yu & Lihui Yu
		
	By:	 	 /s/ Peter Yu

		
	Name:	 	Peter Yu
		
	By:	 	 /s/ Lihui Yu

		
	Name:	 	Lihui Yu
	
	Email: peteryu@us1america.com
	
	 Address: 8755 NW 35th

                Lane Miami, FL 33172

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	INVESTORS:
	
	H&H Yeung Corporation
		
	By:	 	 /s/ Hoi-Sang Yeung

		
	Name:	 	Hoi-Sang Yeung
		
	Title:	 	Director
		
	Email:	 	Kelly.Yeung@irmgusa.com, wanting.jin@irmgusa.com
	
	 Address: 4531 Ponce De Leon Blvd., Ste 300

                Coral Gables, FL 33146

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	INVESTORS:
	
	Medmira Capital Ltd.
		
	By:	 	 /s/ Peter Sun

		
	Name:	 	Peter P. Sun
		
	Title:	 	CEO
		
	Email:	 	petersun@beike.cc
	
	 Address: Room 3, 27/F Hoking Commercial Centre

                No. 2-16Fa Yuen
Street
                 Mong Kok, Kowloon, Hong Kong

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties have executed this AMENDED AND RESTATED
INVESTORS’ RIGHTS AGREEMENT as of the date first written above. 
  

			
	INVESTORS:
	
	Pacific Treasure Global Limited, a British Virgin Islands company
		
	By:	 	 /s/ Carol Yu

		
	Name:	 	Carol Yu
		
	Title:	 	Director
		
	Email:	 	jasminehou@virtuesholding.cn lianghao@virtuesholding.cn
	
	 Address: 3102, LHT Tower, 31 Queens Road

                Central, Hong Kong

  
 SIGNATURE PAGE TO
SERIES C PREFERRED AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 SCHEDULE A 

INVESTORS 
  

					
	 Investor
	  	 Address
	  	 Email Address

	 Dr. Hing C. Wong and Bee Yau Huang
	  	2966 Wentworth
Weston, FL 33332	  	hingwong@hcwbiologics.com
			
	 Golden Triangle Ventures, LLC
	  	400 South El Camino Real, Suite
1200, San Mateo, CA 94402	  	fmiddleton@Sanderling.com
BBloxham@Sanderling.com
			
	 Deepwork HCW Partners LLC
	  	1030 N. Orange Avenue, Suite 101
Orlando, FL 32801	  	kathy@deepworkcapital.com
mitchel@deepworkcapital.com
			
	 Axone Ventures HCW LP
	  	4340 Von Karman Avenue, Suite
250, Newport Beach, CA 92660	  	fzhang@axonecapital.com
			
	 Loblolly Fund LLC
	  	824 NW Boulevard
Gainesville, FL 32601	  	jpengels@hotmail.com
			
	 Chris Cheung & Ling Cheung
	  	6 Reinsway Circle
Westford, MA 01886	  	gucheung29@gmail.com
			
	 Stanley Yu & Winnie Yu
	  	9518 Swift Creek Circle
Dover, FL 33527	  	stanley.yu@tpa-food.com
			
	 Peter Yu & Lihui Yu
	  	8755 NW 35th Lane
Miami, FL 33172	  	peteryu@us1america.com
			
	 Medmira Capital Ltd.
	  	Room 3, 27/F Hoking Commercial
Centre, No.2-16Fa Yuen Street,
Mong Kok, Kowloon, Hong Kong	  	petersun@beike.cc
			
	 H&H Yeung Corporation
	  	4531 Ponce De Leon Blvd.,
Suite 300
Coral Gables, FL 33146	  	Kelly.yeung@irmgusa.com
Wanting.jin@irmgusa.com
			
	 Pacific Treasure Global Limited
	  	3102, LHT Tower
31 Queens Road
Central, Hong Kong	  	jasminezhou@virtuesholding.cn

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00328-of-00352.parquet"}]]